Michael Kvorjak

Michael Kvorjak

Auto-generated profile, based on publicly available information

Michael Kvorjak

University of Pittsburgh School of Medicine, Department of Surgery

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ERElisa Ruffo
Elisa Ruffo
ABAdam A. Butchy
Adam A. Butchy
YTYaniv Tivon
Yaniv Tivon
VSVictor So
Victor So
MKMichael Kvorjak
Michael Kvorjak
JLJason Lohmueller
Jason Lohmueller
Chimeric antigen receptors (CARs) and synthetic Notch (synNotch) receptors are engineered cell-surface receptors that sense a target antigen and respond by activating T cell receptor signaling or a customized gene program, respectively. Here, to expand the targeting capabilities of these receptors, we develop “universal” receptor systems for which receptor specificity can be directed post-translationally via covalent attachment of a co-administered antibody bearing a benzylguanine (BG) motif. A SNAPtag self-labeling enzyme is genetically fused to the receptor and reacts with BG-conjugated antibodies for covalent assembly, programming antigen recognition. We demonstrate that activation of SNAP-CAR and SNAP-synNotch receptors can be successfully targeted by clinically relevant BG-conjugated antibodies, including anti-tumor activity of SNAP-CAR T cells in vivo in a human tumor xenograft mouse model. Finally, we develop a mathematical model to better define the parameters affecting universal receptor signaling. SNAP receptors provide a powerful strategy to post-translationally reprogram the targeting specificity of engineered cells.

15 June 2021 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SKShunsuke Kataoka
Shunsuke Kataoka
PMPriyanka Manandhar
Priyanka Manandhar
JLJudong Lee
Judong Lee
CWCreg J. Workman
Creg J. Workman
HBHridesh Banerjee
Hridesh Banerjee
LKLawrence P. Kane
Lawrence P. Kane
The transmembrane receptor Tim-3 is recruited to the immune synapse of T cells, where it provides costimulatory signals.

23 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMichael Kvorjak
Michael Kvorjak
ERElisa Ruffo
Elisa Ruffo
YTYaniv Tivon
Yaniv Tivon
VSVictor So
Victor So
APAvani B. Parikh
Avani B. Parikh
JLJason Lohmueller
Jason Lohmueller
As living drugs, engineered T cell therapies are revolutionizing disease treatment with their unique functional capabilities. However, they suffer from limitations of potentially unpredictable behavior, toxicities, and non-traditional pharmacokinetics. Engineering conditional control mechanisms responsive to tractable stimuli such as small molecules or light is thus highly desirable. We and others previously developed “universal” chimeric antigen receptors (CARs) that interact with co-administered antibody adaptors to direct target cell killing and T cell activation. Universal CARs are of high therapeutic interest due to their ability to simultaneously target multiple antigens on the same disease or different diseases by combining with adaptors to different antigens. Here, we further enhance the programmability and potential safety of universal CAR T cells by engineering OFF-switch adaptors that can conditionally control CAR activity, including T cell activation, target cell lysis, and transgene expression, in response to a small molecule or light stimulus. Moreover, in adaptor combination assays, OFF-switch adaptors were capable of orthogonal conditional targeting of multiple antigens simultaneously following Boolean logic. OFF-switch adaptors represent a robust new approach for precision targeting of universal CAR T cells with potential for enhanced safety.


4 April 2023
Verified
Other
Open access
MKMichael Kvorjak
Michael Kvorjak
YAYasmine Ahmed
Yasmine Ahmed
MMMichelle L. Miller
Michelle L. Miller
RSRaahul Sriram
Raahul Sriram
CCClaudia Coronnello
Claudia Coronnello
SCSandra Cascio
Sandra Cascio
ST6GALNAC1 induces migratory properties of colon cancer cells.

4 April 2023
Verified
Other
Open access
MKMichael Kvorjak
Michael Kvorjak
YAYasmine Ahmed
Yasmine Ahmed
MMMichelle L. Miller
Michelle L. Miller
RSRaahul Sriram
Raahul Sriram
CCClaudia Coronnello
Claudia Coronnello
SCSandra Cascio
Sandra Cascio
IL-13 and CCL17 induce ST6GALNAC1 and sTn expression in SW480 colon cancer cells